<?xml version='1.0' encoding='utf-8'?>
<document id="23153057"><sentence text="Assessment of cytochrome P450 (1A2, 2B6, 2C9 and 3A4) induction in cryopreserved human hepatocytes cultured in 48-well plates using the cocktail strategy." /><sentence text="1" /><sentence text=" A fast, straightforward and cost-effective assay was validated for the assessment of CYP induction in cryopreserved human hepatocytes cultured in 48-well plates" /><sentence text=" The cocktail strategy (in situ incubation) was used to assess the induction of CYP1A2, CYP2B6, CYP2C9 and CYP3A4 by using the recommended probe substrate, i" /><sentence text="e" /><sentence text=" phenacetin, bupropion, diclofenac and midazolam, respectively"><entity charOffset="1-11" id="DDI-PubMed.23153057.s6.e0" text="phenacetin" /><entity charOffset="13-22" id="DDI-PubMed.23153057.s6.e1" text="bupropion" /><entity charOffset="24-34" id="DDI-PubMed.23153057.s6.e2" text="diclofenac" /><entity charOffset="39-48" id="DDI-PubMed.23153057.s6.e3" text="midazolam" /><pair ddi="false" e1="DDI-PubMed.23153057.s6.e0" e2="DDI-PubMed.23153057.s6.e0" /><pair ddi="false" e1="DDI-PubMed.23153057.s6.e0" e2="DDI-PubMed.23153057.s6.e1" /><pair ddi="false" e1="DDI-PubMed.23153057.s6.e0" e2="DDI-PubMed.23153057.s6.e2" /><pair ddi="false" e1="DDI-PubMed.23153057.s6.e0" e2="DDI-PubMed.23153057.s6.e3" /><pair ddi="false" e1="DDI-PubMed.23153057.s6.e1" e2="DDI-PubMed.23153057.s6.e1" /><pair ddi="false" e1="DDI-PubMed.23153057.s6.e1" e2="DDI-PubMed.23153057.s6.e2" /><pair ddi="false" e1="DDI-PubMed.23153057.s6.e1" e2="DDI-PubMed.23153057.s6.e3" /><pair ddi="false" e1="DDI-PubMed.23153057.s6.e2" e2="DDI-PubMed.23153057.s6.e2" /><pair ddi="false" e1="DDI-PubMed.23153057.s6.e2" e2="DDI-PubMed.23153057.s6.e3" /></sentence><sentence text=" 2" /><sentence text=" Cryopreserved human hepatocytes were treated for 72 h with prototypical reference inducers, β-naphthoflavone (25 µM), phenobarbital (500 µM) and rifampicin (10 µM) as positive controls for CYP induction"><entity charOffset="93-109" id="DDI-PubMed.23153057.s8.e0" text="β-naphthoflavone" /><entity charOffset="119-132" id="DDI-PubMed.23153057.s8.e1" text="phenobarbital" /><entity charOffset="146-156" id="DDI-PubMed.23153057.s8.e2" text="rifampicin" /><pair ddi="false" e1="DDI-PubMed.23153057.s8.e0" e2="DDI-PubMed.23153057.s8.e0" /><pair ddi="false" e1="DDI-PubMed.23153057.s8.e0" e2="DDI-PubMed.23153057.s8.e1" /><pair ddi="false" e1="DDI-PubMed.23153057.s8.e0" e2="DDI-PubMed.23153057.s8.e2" /><pair ddi="false" e1="DDI-PubMed.23153057.s8.e1" e2="DDI-PubMed.23153057.s8.e1" /><pair ddi="false" e1="DDI-PubMed.23153057.s8.e1" e2="DDI-PubMed.23153057.s8.e2" /></sentence><sentence text=" The use of a cocktail strategy has been validated and compared to the classical approach (single incubation)" /><sentence text=" The need of using phase II inhibitor (salicylamide) in CYP induction assay was also investigated"><entity charOffset="39-51" id="DDI-PubMed.23153057.s10.e0" text="salicylamide" /></sentence><sentence text=" 3" /><sentence text=" By using three different batches of cryopreserved human hepatocytes and our conditions of incubations, we showed that there was no relevant drug-drug interaction using the cocktail strategy" /><sentence text=" The same conclusions were observed when a broad range of enzyme activity has to be assessed (wide range of reference inducers, i" /><sentence text="e" /><sentence text=" EC50-Emax experiment)" /><sentence text=" In addition, the interassay reproducibility assessment showed that the day-to-day variability was minimal" /><sentence text=" 4" /><sentence text=" In summary, the study showed that the conditions used (probe substrates, concentration of probe substrate and time of incubation) for the cocktail approach were appropriate for investigations of CYP induction potential of new chemical entities" /><sentence text=" In addition, it was also clear that the use of salicylamide in the incubation media was not mandatory and could generate drug-drug interactions"><entity charOffset="48-60" id="DDI-PubMed.23153057.s19.e0" text="salicylamide" /></sentence><sentence text=" For this reason, we recommend to not use salicylamide in CYP induction assay"><entity charOffset="42-54" id="DDI-PubMed.23153057.s20.e0" text="salicylamide" /></sentence><sentence text="" /></document>